Skip to main content
. 2004 Sep 16;561(Pt 1):1–25. doi: 10.1113/jphysiol.2004.068197

Table 1.

Summary of exercise training studies of conduit and/or resistance vessel function in healthy humans and subjects with cardiovascular disease and risk factors

Study Methods Exercise training Effect of NO-mediated vasodilator function NO improvement?
Normal subjects:
 Localized exercise
  Green et al. 1994 Healthy young controls. VOP Handgrip, 4 weeks, 3 × weekly No difference in ACh, SNP or l-NMMA responses after training. Peak reactive hyperaemia improved
Franke et al. 1998 Young healthy subjects. VOP Handgrip, 4 weeks, 3 × weekly Response to exercise increased. No change in ACh + exercise responses
Bank et al. 1998 Controls for study of CHF patients. VOP Handgrip, 30 min, 4–6 times/week  ACh improved after training. No change SNP
 Whole body exercise
Kingwell et al. 1997b Male sedentary 4 week cycle training. VOP Cycling, 4 weeks, 3 × weekly, 30 min Training ↑l-NMMA response at 2 μmol only. No difference ACh or SNP a
First suggestion that leg training improves forearm responses b
Bergholm et al. 1999 Fit young males. VOP Running. High intensity 4 × 1 h running session, weekly ACh and l-NMMA ↓ after training. No change SNP. Effect may be due to ↓ antioxidant concentrations
Clarkson et al. 1999 Healthy army recruits Brachial D/U Running, 10 weeks Daily 3 mile run + strength sessions High volume exercise FMD increased from 2.2 to 3.9%. No change GTN
Higashi et al. 1999a Middle-aged controls for study of hypertensives. VOP Walking, 30 mins, 5–7/week, 12 weeks ACh response increased. No change in isosorbide dinitrate
DeSouza et al. 2000 Normal middle aged sedentary. VOP Walking, 3 months home basedNo control group or period Training improved ACh responses. No changes in SNP responses
Maiorana et al. 2001b Normals. Middle-aged. VOP Circuit training, 8 weeks, 3 × week No changes ACh or SNP or l-NMMA
Goto et al. 2003 Normal young males. VOP Cycle exercise, 30 min, 5–7 × weekly, 12 weeks Moderate intensity improved ACh responses. l-NMMA abolished this improvement c
25%, 50% and 75% groups No improvement in low or high intensity groups
Oxidant stress increased, high intensity group d
e
CHF
 Localized exercise
Hornig et al. 1996 Radial artery D/U Handgrip, 4 weeks training, daily for 30 min Training improved FMD, especially the l-NMMA sensitive component
Katz et al. 1997 VOP Handgrip, 30 min daily, 8 weeks Yes ACh ↑. GTN no change
Bank et al. 1998 VOP Handgrip, 30 min, 4-6 times/weeks No improvement in ACh responses after training. No change SNP
Hambrecht et al. 2000b Radial D/U Handgrip, 6 × daily, 4 weeks ACh dilatation increased, l-arginine potentiated the effect. No change in GTN
Whole body exercise
Hambrecht et al. 1998 Doppler flow velocity + angiography of femoral artery Cycle training, 6 months, 6 × day, 10 min, 80% HRmax ACh mediated blood flow response increased. l-NMMA response also increased. No change GTN.
Maiorana et al. 2000 VOP. Circuit training, 8 weeks, 3× week ACh increased. SNP response also significantly improved.
Linke et al. 2001 Radial artery D/U. 4 weeks cycle training, 6 × day, 10 min, 80% HRmax Leg training improved ACh and FMD responses in the forearm. No change in GTN.
CAD
Whole body exercise
Hambrecht et al. 2000c Coronary bed. Flow wire/Doppler Cycle training, 6 × day, 10 min, 4 weeks 80% HRmax ACh responses and peak flow velocity improved.
Gielen et al. 2003 Coronary bed Intravascular ultrasound/angiography Home based follow-up to above study ACh responses improved, improved flow and velocity to ACh. No changes in response to GTN.
Bicycle exercise, 20 min daily, 5 months
Gokce et al. 2002b Brachial and tibial D/U Leg exercise, 40 min, 3x weekly, 10 weeks FMD increased significantly in the tibial artery, with increase (NS) also in the brachial. No changes in GTN responses.
Walsh et al. 2003a Brachial D/U Circuit training, 8 weeks, 3 × week FMD improved. No change in GTN
Hambrecht et al. 2003 Coronary bed Intravascular ultrasound/angiography Cycle or rowing, 3 × day, 10 min, 4 weeks Peak flow velocity response to ACh increased eNOS expression and phosphorylation increased in coronary artery samples.
Hypertensives
Whole body exercise
Higashi et al. 1999a VOP Walking, 30 mins, 5-7/week, 12 weeks ACh increase sig in hypertensives. No difference isosorbide dinitrate LNNMA abolished training enhancement in ACh response.
Higashi et al. 1999b VOP Walking, 30 mins, 5-7/week, 12 weeks Max RHBF response increased only in hypertensives l-NMMA abolished thins enhancement
Hypercholesterolaemia
Whole body exercise
Lewis et al. 1999 Hyperchols not medicated. VOP Cycle training, 4 weeks, 3 × 30 min/week l-NMMA responses greater after training at 4 μmol. No effect of training on ACh or SNP responses f
Walsh et al. 2003b Hyperchols on and off medication.VOP and Brachial D/U Circuit training, 8 weeks, 3 × week ACh and FMD responses improved in overall and in medicated subjects. No change SNP or GTN. l-NMMA improved in unmedicated subjects. h
Obesity
Whole body exercise
Sciacqua et al. 2003 Adults. VOP Walking, 30 min daily, 3 × weekly, 10–16 weeks In those who lost weight: improved response to upper dose of AChNo change in SNP responses
Watts et al. 2004a Adolescents. Brachial D/U Circuit training, 8 weeks, 3 × week FMD increased. Improvement not related to change in adiposity
Watts et al. 2004b Children. Brachial D/U Structured play/games, 1 h, 3 × week FMD increased
Woo et al. 2004 Overweight children. Brachial D/U Diet + exercise versus diet alone design At 6 weeks, both group improved FMD
Diabetes
Whole body exercise
Lavrencic et al. 2000 Polymetabolic syndrome. Brachial D/U Bicycle exercise, 3 × weekly, 12 weeks FMD increased. No change in GTN responses
Maiorana et al. 2001a Type 2 diabetics. VOP and Brachial D/U Circuit training, 8 weeks, 3 × week ACh and FMD increased. No change in SNP or GTN
Fuchsjager-Mayrl et al. 2002 Type 1 diabetes. Brachial D/U Cycle exercise, 1 h, 2–3× weekly, 4 months FMD increased significantly. No significant change in GTN, despite trend

VOP, venous occlusion plethysmography; D/U, Doppler ultrasound arterial assessment; l-NMMA, NG-monomethyl-l-arginine: ACh, acetylcholine, an endothelium-dependent NO vasodilator; SNP, sodium nitroprusside, an endothelium-independent NO vasodilator; FMD, flow-mediated vasodilatation, an endothelium- and NO-dependent vasodilator stimulus; GTN, glyceryl trinitrate, an endothelium-independent vasodilator; CHF, chronic heart failure; CAD, coronary artery disease; ↑, improvement in NO vasodilator function; ↓, deterioration in NO vasodilator function; ↔, no change in NO vasodilator function. aStimulated function; bbasal function; clow intensity; dmoderate intensity; ehigh intensity; fbasal function; gstimulated function; hbasal function in unmedicated subjects; istimulated function in unmedicated subjects; jmedicated subjects.